Get In Touch

Cancer is defined as the abnormal growth of cells in the body. Cells located at any part of the body can turn cancerous and spread to other parts of the body. Liver cancer begins in the cells of the liver. Several kinds of cancer can form in the liver. Hepatocellular carcinoma is considered to be the most common liver cancer and begins in the hepatocyte. Other types of liver cancer include hepatoblastoma and intrahepatic cholangiocarcinoma. These are considered to be less common. According to the American Society of Clinical Oncology (ASCO), around 80% of adult primary liver cancers are hepatocellular carcinomas. Liver cancer diagnostics include techniques used for liver cancer identification and confirmation.

According to the World Cancer Research Fund, in 2018, nearly 840,000 new cases of liver cancer were diagnosed globally. Liver cancer is considered to be the fifth most common cancer among men and the ninth most common cancer among women. According to the Centers for Disease Control and Prevention (CDC), around 33,000 people are diagnosed with liver cancer in the U.S. every year, and about 26,000 people succumb to the disease. The percentage of people in the U.S. suffering from liver cancer has been increasing for several decades. According to the Department of Health in New York State, nearly 1,500 men and 600 women are diagnosed with liver cancer every year. Approximately 900 men and 500 women in New York succumb to liver cancer each year.

Rise in prevalence of liver cancer, high alcohol consumption, research & development activities including development of newer techniques for the diagnosis of liver cancer, availability of efficient cancer treatments, and rise in adoption of new techniques for detection of liver cancer are anticipated to boost the global liver cancer diagnostics market. However, the shortage of skilled professionals and lack of awareness about the technological advancements are expected to hamper the growth of the liver cancer diagnostics market.                                   

In terms of screening type, the global liver cancer diagnostics market can be segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The laboratory tests segment can be bifurcated into biomarkers and blood tests. The laboratory tests segment is anticipated to account for the largest market share during the forecast period, attributed to increasing in a requirement for effective diagnostic tests for hepatocellular carcinoma. The biomarkers segment can be divided into molecular markers, oncofetal & glycoprotein antigens, pathological biomarkers, growth factors & receptors, and enzymes & isoenzymes. In terms of end-user, the liver cancer diagnostics market can be categorized into hospital associated laboratories, independent diagnostic laboratories, and others. The hospital associated laboratories segment is anticipated to account for the largest share of the global liver cancer diagnostics market, owing to an increase in the number and well-equipped infrastructure of hospitals.

In terms of region, the global liver cancer diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global liver cancer diagnostics market due to technological advancements, increase in demand for care diagnostics, and rapid adoption of novel diagnostics and therapeutic approaches. The liver cancer diagnostics market in the Asia Pacific is anticipated to witness strong growth, attributed to increases in population, a rise in prevalence of liver cancer, surge in initiatives by a government in health care, increase in research and development activities.

Key players operating in the global liver cancer diagnostics market are Illumina, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., QIAGEN, Siemens Healthcare Private Limited, Danaher, Foundation Medicine, Inc., Biocept, Inc., Koninklijke Philips N.V., and Hologic, Inc. These players have adopted strategies such as partnerships, agreements, collaborations, partnerships, and new product development to gain a competitive advantage in the global liver cancer diagnostics market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Liver Cancer Diagnostics Market

Pre Book